Indian Sun Pharma Acquires American Ogenon for $12 Billion
Indian pharmaceutical company Sun Pharma has announced its agreement to acquire American firm Ogenon, specializing in women's healthcare, in a deal valued at <strong>$12 billion</strong>. This acquisition is one of the largest outbound Indian deals in recent years.